Diseases and Conditions Researched
Alcohol Abuse; Alcohol Dependence; Smoking
What is the purpose of this trial?
The purpose of this study is to determine whether Varenicline is effective in the treatment of alcohol dependence in smokers. Participants will be compensated a total of $525 cash over a 1 year period of time.
Participation Guidelines
Age: 18 Years - 70 Years
Gender: Both
Click here for
detailed participation information for this trial.
|
Sponsor:
|
Yale University |
| Study HIC#: |
1106008598 |
Conditions
Alcohol Abuse; Alcohol Dependence; Smoking
Trial Purpose
The purpose of the study is to determine whether Varenicline is effective in the treatment of alcohol dependence in smokers. Building upon knowledge about the role of nicotinic acetylcholine receptors in alcohol drinking and smoking, Varenicline, a smoking cessation treatment that targets these receptors, will be tested as a potential treatment for alcohol dependent smokers seeking alcohol treatment.
Participation Guidelines
Age: 18 Years - 70 Years
Gender: Both
Eligibility Criteria
Inclusion Criteria:
- must be seeking treatment for alcohol drinking
- met DSM-IV TR Criteria for Alcohol Dependence
- smoke at least 5 cigarettes a day for the 6 months or more and have a CO of greater than 10ppm.
- report heavy drinking on at least 2 days on average per week (i.e.: more than 4 drinks on an occasion for women and 5 or more drinks for men) for the past 90 days and no more than 7 consecutive days of abstinence at study intake
Exclusion Criteria:
- exhibit current, clinically significant physical disease or abnormality based on medical history, physical examination, or routine laboratory evaluation
- have a history of cancer (except treated basal cell or squamous cell carcinoma of the skin)
- have a history of clinically signficant allergic reactions
- have a Body Mass Index (calculated as weight in kilograms divided by the square of height in meters) less than 15 or greater than 38 or weight less than 45 kg
- are a female of childbearing potential who is pregnant, nursing, or not practicing effective contraception (oral, injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide)
|
Sponsor:
|
Yale University |
| Study HIC#: |
1106008598 |